Pathological complete response after neoadjuvant treatment determines survival in esophageal squamous cell carcinoma patients (NEOCRTEC5010)

BACKGROUND: Few studies have exclusively investigated the value of pathological complete response (pCR), in esophageal squamous cell carcinoma (ESCC) patients, although it is a clinically significant parameter to evaluate the impact of neoadjuvant chemoradiotherapy (nCRT) on treatment outcome after...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Jianfei, Kong, Min, Yang, Hong, Jin, Ke, Chen, Yuping, Fang, Wentao, Yu, Zhentao, Mao, Weimin, Xiang, Jiaqing, Han, Yongtao, Chen, Zhijian, Yang, Haihua, Wang, Jiaming, Pang, Qingsong, Zheng, Xiao, Yang, Huanjun, Li, Tao, Zhang, Xu, Li, Qun, Wang, Geng, Mao, Teng, Guo, Xufeng, Lin, Ting, Liu, Mengzhong, Ma, Dehua, Ye, Minhua, Wang, Chunguo, Wang, Zheng, Brunelli, Alessandro, Cerfolio, Robert J., D’Journo, Xavier Benoit, Fernando, Hiran C., Lordick, Florian, Fu, Jianhua, Chen, Baofu, Zhu, Chengchu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576689/
https://www.ncbi.nlm.nih.gov/pubmed/34790722
http://dx.doi.org/10.21037/atm-21-3331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576689/
https://www.ncbi.nlm.nih.gov/pubmed/34790722
http://dx.doi.org/10.21037/atm-21-3331

Ejemplares similares